That’s because drug prices and payments are negotiated as part of a package of drugs that are covered by the insurer called a ...

A $50,000-per-dose threshold for clinician-administered drugs can standardize high-cost identification, while allowing ...

Successful formulary system management can help ACOs achieve high quality, low cost objectives across the care continuum. This article targets healthcare leaders choosing to participate in the ...

Insurers are putting a growing focus on specialty drugs covered under the medical benefit, and on re-evaluating the efficacy ...

NYU Langone files $24M plan to upgrade hospital's cardiology facilities Patient-monitoring tech startup raises $130M for global expansion Columbia launches simulation to prep hospital executives for ...

A key feature of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) is its reliance on private insurers (stand alone-drug insurers and Medicare Advantage plans) to ...

Health systems’ pharmaceutical spending is expected to rise by up to 6 percent in 2019, according to a study published in the American Journal of Health-System Pharmacy. For these organizations — ...

FILE - Packaging for AbbVie's drug, Humira. Patients who take the autoimmune disease treatment can get some price relief when lower-cost, biosimilar versions are included on health plan formularies.

An Assembly bill that prevents health plans from removing a prescription drug from their formulary, or add new restrictions during a contract year, advanced to the next step Thursday. Opponents ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...